RNA, U6 small nuclear 266, pseudogene (RNU6-266P)

RNA, U6 small nuclear 266, pseudogene (RNU6-266P) refers to a genomic locus resembling the functional U6 snRNA gene but classified as a pseudogene. U6 snRNA itself is part of the spliceosome complex, essential for pre-mRNA splicing in eukaryotes[3]; the pseudogene variant RNU6-266P does not produce a functional RNA molecule and is considered non-functional. Pseudogenes are generally remnants of once-functional genes, occasionally participating in regulatory RNA crosstalk but not typically serving as drug targets or biomarkers[4]. There is no evidence that RNU6-266P has a role in disease, biological processes, drug interactions, or clinical utility. Specifically, no biological functions are established for RNU6-266P, as pseudogenes do not have a confirmed biological function. No direct disease roles are established; although some pseudogenes can have regulatory functions or be linked to diseases, this is not documented for RNU6-266P. There are no documented interacting drugs as pseudogenes do not have direct drug interactions, and consequently, no mechanism of action is applicable. No biomarkers are known for RNU6-266P; while functional U6 snRNA forms may be used as qPCR controls, this does not apply to the pseudogene. No safety concerns are applicable. The parent molecule, U6 snRNA, is ubiquitous, evolutionarily conserved, and essential to the spliceosome[3]. While many pseudogenes can be transcribed or play regulatory roles, this is rare and not described for RNU6-266P. Pseudogenes named by the format "RNA, U6 small nuclear [number], pseudogene" are widespread in the human genome and serve no confirmed function, clinical use, or therapeutic utility[3][4]. In summary, RNU6-266P is a noncoding RNA pseudogene, not a therapeutic or pharmacological target, and is not known to have biological, disease, or drug-related roles.

Other names

RNU6-266PU6 small nuclear RNA pseudogene 266

Not applicable.